Weed, Inc. (BUDZ): Operating Cash Flow

Annual figures by period end, from SEC filings.

-$195.1K
Year ended 2025-12-31
-$201.1K
Trailing 12 months to 2026-06-30
2010-12-31: -$139.6K2011-12-31: -$123.7K2017-12-31: -$670.2K2018-12-31: -$3.18M2019-12-31: -$1.11M2020-12-31: -$431.0K2021-12-31: -$568.9K2022-12-31: -$813.0K2023-12-31: -$1.07M2024-12-31: -$415.5K2025-12-31: -$195.1K-$195.1K
2010-12-31 Operating Cash Flow (USD) 2025-12-31
Period endedOperating Cash FlowChange YoYSource filing
2025-12-31-$195.1Kn/m2026-04-08, From 2025-01-01
2024-12-31-$415.5Kn/m2026-04-08, From 2024-01-01
2023-12-31-$1.07Mn/m2025-03-31, From 2023-01-01
2022-12-31-$813.0Kn/m2024-04-01, From 2022-01-01
2021-12-31-$568.9Kn/m2023-03-31, From 2021-01-01
2020-12-31-$431.0Kn/m2022-03-31, From 2020-01-01
2019-12-31-$1.11Mn/m2021-03-31, From 2019-01-01
2018-12-31-$3.18Mn/m2020-03-30, From 2018-01-01
2017-12-31-$670.2Kn/a2019-04-16, From 2017-01-01
No annual figure between 2011-12-31 and 2017-12-31.
2011-12-31-$123.7Kn/m2012-04-16, From 2011-01-01
2010-12-31-$139.6Kn/a2012-04-16, From 2010-01-01

Operating Cash Flow at similar companies

Companies with the same SEC industry code (Services-Commercial Physical & Biological Research), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating Cash FlowChange YoY
Weed, Inc. (BUDZ)2025-12-31-$195.1Kn/m
NRC Health (NRC)2025-12-31$26.45M-23.6%
Incyte Corp (INCY)2025-12-31$1.41B+321.5%
Icon PLC (ICLR)2025-12-31$1.04B-19.5%
Charles River Laboratories International, Inc. (CRL)2025-12-27$737.65M+0.4%
MaxCyte, Inc. (MXCT)2025-12-31-$34.41Mn/m
Cannabis Bioscience International Holdings, Inc. (CBIH)2025-05-31-$329.6Kn/m
Iqvia Holdings Inc. (IQV)2025-12-31$2.65B-2.3%
iSpecimen Inc. (ISPC)2025-12-31-$4.24Mn/m

Compare BUDZ, NRC, INCY, ICLR side by side · Screen every company in Services-Commercial Physical & Biological Research ↗